[(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,6S)-6-[(2R,3R,4S,6S)-6-[(2R,3R,4S,6S)-6-[(2'R,3'R,4S,4'R,5aR,6R,8S,9aR)-8-[(1S)-1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethoxy]-4'-methoxy-2',6-dimethylspiro[6,8,9,9a-tetrahydro-5aH-pyrano[3,4-f][1,3,5]trioxepine-4,6'-oxane]-3'-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-5-hydroxy-4-methoxy-6-methyloxan-3-yl] acetate

Details

Top
Internal ID 15d23280-bcbc-49fb-bd71-368c83aadd7c
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name [(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,6S)-6-[(2R,3R,4S,6S)-6-[(2R,3R,4S,6S)-6-[(2'R,3'R,4S,4'R,5aR,6R,8S,9aR)-8-[(1S)-1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethoxy]-4'-methoxy-2',6-dimethylspiro[6,8,9,9a-tetrahydro-5aH-pyrano[3,4-f][1,3,5]trioxepine-4,6'-oxane]-3'-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-5-hydroxy-4-methoxy-6-methyloxan-3-yl] acetate
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4C(OC(CC4OC)OC5C(OC6(CC5OC)OCOC7CC(OC(C7O6)C)OC(C)C8(CCC9C8(CCC1C9CC=C2C1(CCC(C2)O)C)C)O)C)C)C)C)OC(=O)C)OC)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2OC)O[C@@H]3[C@H](O[C@H](C[C@@H]3OC)O[C@@H]4[C@H](O[C@H](C[C@@H]4OC)O[C@@H]5[C@H](O[C@]6(C[C@H]5OC)OCO[C@@H]7C[C@@H](O[C@@H]([C@H]7O6)C)O[C@@H](C)[C@]8(CC[C@@H]9[C@@]8(CC[C@H]1[C@H]9CC=C2[C@@]1(CC[C@@H](C2)O)C)C)O)C)C)C)C)OC(=O)C)OC)O
InChI InChI=1S/C65H106O24/c1-31-53(68)59(74-15)60(83-38(8)66)61(81-31)87-56-34(4)79-51(27-46(56)72-13)85-54-32(2)77-50(25-44(54)70-11)84-55-33(3)78-52(26-45(55)71-12)86-57-36(6)88-65(29-48(57)73-14)76-30-75-47-28-49(80-35(5)58(47)89-65)82-37(7)64(69)23-20-43-41-17-16-39-24-40(67)18-21-62(39,9)42(41)19-22-63(43,64)10/h16,31-37,40-61,67-69H,17-30H2,1-15H3/t31-,32-,33-,34-,35-,36-,37+,40+,41-,42+,43+,44+,45+,46+,47-,48-,49+,50+,51+,52+,53+,54-,55-,56-,57-,58-,59+,60-,61+,62+,63+,64+,65+/m1/s1
InChI Key ZZNYTIQKQNIAFL-MAJNGXEJSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C65H106O24
Molecular Weight 1271.50 g/mol
Exact Mass 1270.70740424 g/mol
Topological Polar Surface Area (TPSA) 262.00 Ų
XlogP 4.70
Atomic LogP (AlogP) 5.86
H-Bond Acceptor 24
H-Bond Donor 3
Rotatable Bonds 17

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,6S)-6-[(2R,3R,4S,6S)-6-[(2R,3R,4S,6S)-6-[(2'R,3'R,4S,4'R,5aR,6R,8S,9aR)-8-[(1S)-1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethoxy]-4'-methoxy-2',6-dimethylspiro[6,8,9,9a-tetrahydro-5aH-pyrano[3,4-f][1,3,5]trioxepine-4,6'-oxane]-3'-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-5-hydroxy-4-methoxy-6-methyloxan-3-yl] acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9779 97.79%
Caco-2 - 0.8631 86.31%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.6714 67.14%
Subcellular localzation Mitochondria 0.7777 77.77%
OATP2B1 inhibitior - 0.8719 87.19%
OATP1B1 inhibitior + 0.8434 84.34%
OATP1B3 inhibitior + 0.9435 94.35%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior + 0.9754 97.54%
P-glycoprotein inhibitior + 0.7489 74.89%
P-glycoprotein substrate + 0.8032 80.32%
CYP3A4 substrate + 0.7604 76.04%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8805 88.05%
CYP3A4 inhibition - 0.7803 78.03%
CYP2C9 inhibition - 0.8253 82.53%
CYP2C19 inhibition - 0.8606 86.06%
CYP2D6 inhibition - 0.9239 92.39%
CYP1A2 inhibition - 0.7651 76.51%
CYP2C8 inhibition + 0.7882 78.82%
CYP inhibitory promiscuity - 0.9147 91.47%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.5438 54.38%
Eye corrosion - 0.9873 98.73%
Eye irritation - 0.9004 90.04%
Skin irritation - 0.5795 57.95%
Skin corrosion - 0.9364 93.64%
Ames mutagenesis - 0.6500 65.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7801 78.01%
Micronuclear - 0.7500 75.00%
Hepatotoxicity - 0.5625 56.25%
skin sensitisation - 0.8678 86.78%
Respiratory toxicity + 0.8222 82.22%
Reproductive toxicity + 0.9778 97.78%
Mitochondrial toxicity + 0.7625 76.25%
Nephrotoxicity - 0.8499 84.99%
Acute Oral Toxicity (c) III 0.3328 33.28%
Estrogen receptor binding + 0.8262 82.62%
Androgen receptor binding + 0.7814 78.14%
Thyroid receptor binding + 0.6202 62.02%
Glucocorticoid receptor binding + 0.8056 80.56%
Aromatase binding + 0.6840 68.40%
PPAR gamma + 0.8373 83.73%
Honey bee toxicity - 0.5770 57.70%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.6400 64.00%
Fish aquatic toxicity + 0.9572 95.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.37% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.18% 96.09%
CHEMBL204 P00734 Thrombin 97.45% 96.01%
CHEMBL1914 P06276 Butyrylcholinesterase 97.37% 95.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 95.85% 95.89%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 95.37% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 94.09% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.98% 89.00%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 92.36% 96.77%
CHEMBL2581 P07339 Cathepsin D 92.06% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.91% 97.25%
CHEMBL226 P30542 Adenosine A1 receptor 91.54% 95.93%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 90.91% 95.71%
CHEMBL340 P08684 Cytochrome P450 3A4 90.44% 91.19%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 90.36% 97.14%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 88.90% 92.62%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.82% 86.33%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 87.84% 85.14%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 87.71% 94.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.60% 97.09%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 86.97% 94.08%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.30% 95.56%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 86.00% 92.88%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 85.97% 97.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.72% 95.89%
CHEMBL3359 P21462 Formyl peptide receptor 1 83.13% 93.56%
CHEMBL5028 O14672 ADAM10 82.98% 97.50%
CHEMBL3714130 P46095 G-protein coupled receptor 6 82.72% 97.36%
CHEMBL5255 O00206 Toll-like receptor 4 82.69% 92.50%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 82.51% 100.00%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 81.85% 91.03%
CHEMBL2959 Q08881 Tyrosine-protein kinase ITK/TSK 81.41% 95.00%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.33% 96.00%
CHEMBL3922 P50579 Methionine aminopeptidase 2 81.26% 97.28%
CHEMBL1871 P10275 Androgen Receptor 80.77% 96.43%
CHEMBL4073 P09237 Matrix metalloproteinase 7 80.46% 97.56%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Periploca sepium

Cross-Links

Top
PubChem 162865073
LOTUS LTS0142742
wikiData Q105386945